Full Text View
Tabular View
No Study Results Posted
Related Studies
Electroacupuncture for Major Depression
This study has been completed.
Study NCT00071110   Information provided by National Center for Complementary and Alternative Medicine (NCCAM)
First Received: October 10, 2003   Last Updated: August 4, 2008   History of Changes

October 10, 2003
August 4, 2008
March 2004
May 2007   (final data collection date for primary outcome measure)
Antidepressant response, defined as a Ham-D relative decrease of 50 % or more and a final score < 10
Same as current
Complete list of historical versions of study NCT00071110 on ClinicalTrials.gov Archive Site
Improvement in functioning and health-related quality of life as rated by the MOS-SF36 or the WHO DAS-S
Same as current
 
Electroacupuncture for Major Depression
Electroacupuncture for Major Depression: A Pilot Study

This study will compare the safety, efficacy, and tolerability of electroacupuncture (EA) and sham electroacupuncture (SA) for the treatment of major depression.

Major depression is a common and serious mental illness. It is associated with a markedly lower quality of life, significant functional impairment, and premature death due to suicide or comorbid physical illness. Over the past 50 years, effective and safe treatments for major depression have been developed, including antidepressant pharmacotherapy, psychotherapy, and electroconvulsive therapy. However, many Americans who suffer from a depressive disorder either do not elect to receive one of these conventional treatments or do not complete an adequate course of treatment. A growing number of Americans with depression are choosing to be treated with complementary and alternative therapies. Acupuncture, in particular, is increasingly being used to treat depression even though only limited data support its safety and efficacy.

This study will use a randomized parallel-group design to compare the safety, efficacy, and tolerability of electroacupuncture (EA) and sham electroacupuncture (SA) for the treatment of major depression. Over a 15-month period, 60 adult outpatients with a major depressive disorder of mild or moderate severity (as defined by the DSM-IV) will be randomized to either 12 sessions of EA or SA to be provided over 6 weeks. Safety and symptomatic improvement (as measured with the Hamilton Rating Scale for Depression [HRSD]) will constitute the primary outcome measures. Tolerability and functional improvement will constitute secondary outcome measures.

Phase II
Interventional
Treatment, Randomized, Single Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
  • Depression
  • Depressive Disorder
Procedure: electroacupuncture
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
60
May 2007
May 2007   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Meet SCID criteria for a Major Depressive Disorder (Single or Recurrent) with a current major depressive episode of mild or moderate severity
  • Significant symptoms of depression (HRSD > 14)
  • Ability to communicate in English
  • Give informed consent in accordance with local IRB regulations

Exclusion Criteria:

  • Personal physician's recommendation against enrollment because the patient is physically unstable or for other reasons
  • Having been treated with acupuncture for any condition
  • History of seizure disorder or significant risk factors for a seizure disorder (e.g., history of brain trauma, recent stroke, or brain tumor)
  • Need to remain on antidepressant or other psychotropic medications
  • Absence of depressive symptoms severe enough (i.e., HRSD < 14) at the baseline assessments
  • Significant cognitive impairment, as assessed by a total score on the MMSE < 25. A recommendation for referral to a neurologist or a psychiatrist will be made to the patient in these cases.
  • Chronic major depression (i.e, duration of 2 years or longer) A recommendation for referral to a psychiatrist will be made in these cases.
  • Major depressive episode severe or severe with psychotic features (as per DSM-IV/SCID) or with acutely suicidality. A recommendation for psychiatric referral will be made in these cases. Bipolar disorder, psychotic features, or a psychotic disorder (specifically: schizophrenia, delusional disorder, or schizoaffective disorder). A recommendation for psychiatric referral will be made in these cases.
  • Met criteria for a diagnosis of alcohol substance abuse or dependence within the past six months. A recommendation for referral to a mental health professional will be made in these cases.
Both
18 Years to 80 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00071110
 
R21 AT001218-01A1
National Center for Complementary and Alternative Medicine (NCCAM)
 
Principal Investigator: Benoit H Mulsant, MD University of Pittsburgh
National Center for Complementary and Alternative Medicine (NCCAM)
August 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP